FOXO3 and breast carcinoma: These findings are confirmed by miRNA feedback inhibition of FOXO3a in the Heceptin-resistant HER2-positive breast cancer cell sublines SKBR3-pool2 (pool2) and BT474-HR20 (HR20) derived from SKBR3 and BT474 [140].